基本情報
- 標準SMILES
CCCn1c(=O)[nH]c(=O)c2[nH]cnc21- InChIKey
SIQPXVQCUCHWDI-UHFFFAOYSA-N- 分子式
- C8H10N4O2
- 平均分子量
- 194.19 g/mol
- 単同位体質量
- 194.08037556
概要
Enprofylline is xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. It has a role as a non-steroidal anti-inflammatory drug, a bronchodilator agent, an anti-arrhythmia drug and an anti-asthmatic drug.
名称と識別子
- 優先名称
- Enprofylline
- IUPAC
- 3-propyl-7H-purine-2,6-dione
- 現地名
- エンプロフィリン
- 英語名
- ENPROFYLLINE
- 分子式
- C8H10N4O2
- 分子量
- 194.19
名称と別名
名称をさらに表示
データベース識別子
- CAS
41078-02-8- PubChem CID
- 1676
- DTXSID
DTXSID9045186- ChEMBL
CHEMBL279898- ChEBI
CHEBI:126237- UNII
- DT7DT5E518
- EC Number
- 255-201-8
- Nikkaji
- J16.542E
物性
構造計算による物性
- XLogP
- 0.3
- 極性表面積
- 78.1 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 3
- 回転可能結合数
- 2
- 重原子数
- 14
- 形式電荷
- 0
- 複雑度
- 268
実験および物理化学的性質
LogP
-0.2
0.33
Solubility
5.68e+00 g/L
>29.1 [ug/mL] (The mean of the results at pH 7.4)
Melting Point
287-289 °C
287 - 289 °C
物理化学的性質
- 融点
- 287 · 287-289 °C
- 比重(密度)
- 1.38 g/cm3 · 1.38 g/cm3
- 貯蔵温度
- 2 · 2-8°C
- 溶解性
- DMSO:可溶
- 外見
- 個体
- 酸解離定数(Pka)
- 10.26 · 10.26±0.20(Predicted)
- 色
- 白い
- CAS データベース
- 41078 · 41078-02-8
安全と法規制
GHS分類
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
安全データ
- wgk
- 3
- rtecs
- UO8439700
- risk_code
- 20/21/22
- hazard_code
- Xn
- safety_code
- 36
化学と産業
薬理情報
Mechanism of Action
Enprofylline inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, enprofylline also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity.
MeSH Pharmacological Classification
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Drugs that are used to treat asthma.
Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.
応用分野
説明3-Propylxanthine is a xanthine derivative that antagonizes adenosine receptors (Kis = 44, 32, and 6.3 μM for A1, A2A, and A2B, respectively) and cAMP phosphodiesterase (Ki = 42 μM). Through these actions, 3-propylxanthine induces smooth muscle relaxation, blocks smooth muscle contraction and VEGF secretion driven by adenosine receptor agonists, and reduces bronchial hyperresponsiveness.
使用Enprofylline is a xanthine lacking adenosine receptor antagonism.
上流・下流製品情報
上流原料
サプライヤー27 社
補足説明
定義ChEBI: Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic n uropathy.
関連反応
関連ノート
読み込み中…